Skip to ContentSkip to Navigation
University of Groningenfounded in 1614  -  top 100 university
About us Practical matters How to find us S. van der Schans, MSc

Publications

Cost comparison analysis of onasemnogene abeparvovec and nusinersen for treatment of patients with spinal muscular atrophy type 1 in the Netherlands

Investing in the Prevention of Communicable Disease Outbreaks: Fiscal Health Modelling—The Tool of Choice for Assessing Public Finance Sustainability

Monitoring physical impact and recovery of pancreatic cancer treatment using consumer wearable health data: A case report

A novel perspective on pharmaceutical R&D costs: opportunities for reductions

Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in The Netherlands

Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands

The impact of patent expiry on drug prices: insights from the Dutch market

Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Recommendations